We are live on ! Find out more
CAG

Crestwood Advisors Group Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.44%
This Fund
S&P 500
This Quarter Est. Return
-2.98%
1 Year Est. Return
+18.44%
3 Year Est. Return
+65.91%
5 Year Est. Return
+80.01%
10 Year Est. Return
+299.27%
AUM
$3.81B
AUM Growth
+$631M
Cap. Flow
+$773M
Cap. Flow %
20.27%
Top 10 Hldgs %
29.22%
Holding
375
New
120
Increased
150
Reduced
78
Closed
10

Top Sells

Rank Stock Value
1
RMD icon
ResMed
RMD
+$23.2M
2
BAC icon
Bank of America
BAC
+$22.8M
3
META icon
Meta Platforms (Facebook)
META
+$18.8M
4
JNJ icon
Johnson & Johnson
JNJ
+$5.4M
5
MRSH
Marsh
MRSH
+$1.65M

Sector Composition

Rank Sector Weight
1 Technology 27.11%
2 Financials 14.66%
3 Healthcare 10.3%
4 Consumer Discretionary 9.44%
5 Consumer Staples 5.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSM icon
326
TSMC
TSM
$2.1T
$228K 0.01%
2,629
+283
+12% +$26.8K
LH icon
327
Labcorp
LH
$25B
$228K 0.01%
+1,135
New +$239K
MET icon
328
MetLife
MET
$61.9B
$228K 0.01%
+3,620
New +$225K
ALL icon
329
Allstate
ALL
$68B
$225K 0.01%
2,022
+18
+0.9% +$1.96K
IWS icon
330
iShares Russell Mid-Cap Value ETF
IWS
$15.6B
$222K 0.01%
2,132
+124
+6% +$13.7K
CSX icon
331
CSX Corp
CSX
$93.4B
$219K 0.01%
7,127
-2,081
-23% -$65.9K
CMA
332
DELISTED
Comerica
CMA
$218K 0.01%
+5,250
New +$249K
SLB icon
333
SLB Ltd
SLB
$73.6B
$217K 0.01%
+3,725
New +$216K
QUAL icon
334
iShares MSCI USA Quality Factor ETF
QUAL
$46.4B
$217K 0.01%
1,645
+141
+9% +$19.3K
RJF icon
335
Raymond James Financial
RJF
$33.8B
$215K 0.01%
+2,142
New +$227K
NVO
336
Novo Nordisk
NVO
$208B
$215K 0.01%
+2,364
New +$208K
ZBH icon
337
Zimmer Biomet
ZBH
$18.2B
$215K 0.01%
1,914
+371
+24% +$47.1K
IWP icon
338
iShares Russell Mid-Cap Growth ETF
IWP
$19.8B
$214K 0.01%
+2,341
New +$224K
CMS icon
339
CMS Energy
CMS
$22.6B
$214K 0.01%
+4,020
New +$233K
TRV icon
340
Travelers Companies
TRV
$78.1B
$212K 0.01%
+1,299
New +$217K
MSEX icon
341
Middlesex Water
MSEX
$1.08B
$212K 0.01%
+3,200
New +$246K
AN icon
342
AutoNation
AN
$7.11B
$212K 0.01%
+1,400
New +$223K
PEG icon
343
Public Service Enterprise Group
PEG
$38.2B
$211K 0.01%
+3,713
New +$228K
CRWD icon
344
CrowdStrike
CRWD
$194B
$210K 0.01%
+5,028
New +$195K
CMPR icon
345
Cimpress
CMPR
$2.39B
$210K 0.01%
+2,994
New +$198K
ETR icon
346
Entergy
ETR
$50.2B
$208K 0.01%
+4,506
New +$220K
AIG icon
347
American International
AIG
$41.7B
$204K 0.01%
+3,366
New +$201K
SCHA icon
348
Schwab U.S Small- Cap ETF
SCHA
$22.2B
$203K 0.01%
9,820
-572
-6% -$12.6K
BSVO icon
349
EA Bridgeway Omni Small-Cap Value ETF
BSVO
$2.42B
$202K 0.01%
+11,069
New +$207K
HBB icon
350
Hamilton Beach Brands
HBB
$311M
$191K 0.01%
+15,400
New +$171K

Similar funds

Crestwood Advisors Group's Q3 2023 Portfolio in Review

As of Q3 2023, Crestwood Advisors Group held 375 positions worth $3.81B, up 20% from $3.18B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Crestwood Advisors Group deployed $773M of net new capital in Q3 2023, opening 120 new positions and adding to 150 existing holdings. Its largest new stake was AllianceBernstein: 2,817,395 shares worth $85.5M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was ResMed, an estimated $23.2M trimmed.

  • Crestwood Advisors Group's largest Q3 2023 buy was AllianceBernstein: 2,817,395 shares worth $85.5M.
  • Crestwood Advisors Group added most to Thermo Fisher Scientific in Q3 2023, an estimated $29.1M increase.
  • Crestwood Advisors Group's biggest Q3 2023 reduction was ResMed, cutting an estimated $23.2M.
  • Crestwood Advisors Group fully exited Focus Financial Partners Inc. Class A in Q3 2023, selling an estimated $1.12M.
  • Crestwood Advisors Group's ten largest holdings make up 29% of its $3.81B portfolio in Q3 2023.
  • Crestwood Advisors Group opened 120 new positions and closed 10 in Q3 2023.
  • Crestwood Advisors Group's portfolio value rose 20% quarter-over-quarter to $3.81B.

Based on Crestwood Advisors Group's 13F filing for Q3 2023, filed 15 Nov 2023.